1681 - 1690 of 6456 Results
Title
Year
-
OPENTitle: Frontostriatal Structural Connectivity and Striatal Glutamatergic Levels in Treatment-Resistant Schizophrenia: An Integrative Analysis of DTI and 1H-MRSJournal Name: Schizophrenia Bulletin OpenPublisher: Oxford University Press (OUP)Vol: 1Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/schizbullopen/sgaa057Best OA location URL: https://academic.oup.com/schizbullopen/advance-article-pdf/doi/10.1093/schizbullopen/sgaa057/34032787/sgaa057.pdfCitation Count: 7
-
OPENTitle: Allosteric modulation of the GTPase activity of a bacterial LRRK2 homolog by conformation-specific NanobodiesJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 477Issue #: 7Start Page: 1203End Page: 1218Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1042/bcj20190843Citation Count: 17
-
OPENTitle: Antiglutamic Acid Decarboxylase 65 Antibody–Associated HemiataxiaJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 11Issue #: 4Start Page: e564End Page: e566Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000000939Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8382435Citation Count: 2
-
OPENTitle: Letter: Evaluation and Surgical Treatment of Functional Neurosurgery Patients With Implanted Deep Brain Stimulation and Vagus Nerve Stimulation Pulse Generators During the COVID-19 PandemicJournal Name: NeurosurgeryPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 87Issue #: 2Start Page: E222End Page: E226Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/neuros/nyaa185Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7239172Citation Count: 8
-
OPENTitle: Brain perfusion patterns are altered in chronic knee pain: a spatial covariance analysis of arterial spin labelling MRIJournal Name: PainPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 161Issue #: 6Start Page: 1255End Page: 1263Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1097/j.pain.0000000000001829Best OA location URL: https://doi.org/10.1097/j.pain.0000000000001829Citation Count: 24
- Frequency of and risk factors for potentially inappropriate medication use in Parkinson’s disease2020OPENTitle: Frequency of and risk factors for potentially inappropriate medication use in Parkinson’s diseaseJournal Name: Age and AgeingPublisher: Oxford University Press (OUP)Vol: 49Issue #: 5Start Page: 786End Page: 792Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/ageing/afaa033Best OA location URL: https://academic.oup.com/ageing/article-pdf/49/5/786/33677028/afaa033.pdfCitation Count: 27
-
OPENTitle: ACValidator: A novel assembly-based approach for in silico verification of circular RNAsJournal Name: Biology Methods and ProtocolsPublisher: Oxford University Press (OUP)Vol: 5Issue #: 1Start Page: bpaa010End Page: bpaa010Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/biomethods/bpaa010Best OA location URL: https://academic.oup.com/biomethods/article-pdf/5/1/bpaa010/33624179/bpaa010.pdfCitation Count: 5
-
OPENTitle: Isolated parkinsonism is an atypical presentation of GRN and C9orf72 gene mutationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: 73End Page: 81Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.019Best OA location URL: https://arxiv.org/pdf/2201.09654Citation Count: 20
-
OPENTitle: The challenge of developing adenosine A2A antagonists for Parkinson disease: Istradefylline, preladenant, and tozadenantJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: S54End Page: S63Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.027Best OA location URL: https://doi.org/10.1016/j.parkreldis.2020.10.027Citation Count: 42
-
OPENTitle: A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 81Issue #:Start Page: 144End Page: 150Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.029Best OA location URL: http://www.prd-journal.com/article/S1353802020308221/pdfCitation Count: 23